Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.6026/97320630016301

http://scihub22266oqcxt.onion/10.6026/97320630016301
suck pdf from google scholar
32773989!7392094!32773989
unlimited free pdf from europmc32773989    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid32773989
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis #MMPMID32773989
  • Hakmi M; Bouricha EM; Kandoussi I; Harti JE; Ibrahimi A
  • Bioinformation 2020[]; 16 (4): 301-306 PMID32773989show ga
  • The new SARS-CoV-2 coronavirus is the causative agent of the COVID-19 pandemic outbreak that affected more than 190 countries worldwide with more than 292,000 confirmed cases and over 12,700 deaths. There is at the moment no vaccine or effective treatment for this disease which constitutes a serious global health problem. It is of interest to use a structure based virtual screening approach for the identification of potential inhibitors of the main protease of SARS-CoV-2 (M(pro)) from antiviral drugs used to treat other viral disease such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections. The crystallographic structure with PDB ID: 6LU7 of M(pro) in complex with the inhibitor N3 was used as a model in the virtual screening of 33 protease inhibitors collected from the ChEMBL chemical database. Molecular docking analysis was performed using the standard AutoDock vina protocol followed by ranking and selection of compounds based on their binding affinity. We report 10 candidates with optimal binding features to the active site of the protease for further consideration as potential drugs to treat patients infected with the emerging COVID-19 disease.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    301 4.16 2020